Literature DB >> 21567465

Reliability of a visual test for the rapid detection of mucopolysaccharidoses: GAG-test(®).

Sergio Lage1, José A Prieto, Fernando Andrade, Amaia Sojo, Pablo Sanjurjo, Luis J Aldámiz-Echevarría.   

Abstract

Mucopolysaccharidoses (MPS) are a group of lysosomal storage disorders, characterized by the deficiency/absence of one of the enzymes involved in the intralysosomal degradation of glycosaminoglycans (GAGs). The quantitative determination of urinary GAGs using dimethylmethylene blue (DMB) shows high reliability. However, the logistics and staff for this method are not always available in primary care centers. Sending urine samples to reference laboratories increases the cost and delays the diagnosis. Thus, the aim of this article is to develop and evaluate a simple and low-cost visual test (GAG-test(®)) for the screening of urine samples from patients under suspicion of suffering from MPS. The purpose is to narrow down the number of samples to be assayed through the quantitative method. A measure of 50 µl urine was added to 2 ml DMB solution. A color change from dark blue to purple indicates an excess of GAGs. The quantitative analyses showed a significant difference between controls' and patients' concentrations (P<0.05). After optimization of the composition, positive and negative results obtained with the qualitative test were able to discriminate between normal urines and those from patients suffering from mucopolysaccharidosis. Therefore, GAG-test(®) has proved to be a useful tool for the prior diagnosis of patients suffering from mucopolysaccharidosis, reducing the number of individuals with whom investigations should be continued.
© 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21567465      PMCID: PMC6647694          DOI: 10.1002/jcla.20453

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  25 in total

1.  Measuring urinary glycosaminoglycans in the presence of protein: an improved screening procedure for mucopolysaccharidoses based on dimethylmethylene blue.

Authors:  J G de Jong; R A Wevers; R Liebrand-van Sambeek
Journal:  Clin Chem       Date:  1992-06       Impact factor: 8.327

2.  Bone marrow transplantation for Hurler syndrome: assessment of metabolic correction.

Authors:  C B Whitley; N K Ramsay; J H Kersey; W Krivit
Journal:  Birth Defects Orig Artic Ser       Date:  1986

3.  Urinary glycosaminoglycan excretion quantified by an automated semimicro method in specimens conveniently transported from around the globe.

Authors:  Chester B Whitley; Richard C Spielmann; Gerrard Herro; Suzanne Severson Teragawa
Journal:  Mol Genet Metab       Date:  2002-01       Impact factor: 4.797

4.  The measurement of urinary mucopolysaccharides.

Authors:  N M Di Ferrante
Journal:  Anal Biochem       Date:  1967-10       Impact factor: 3.365

5.  A new basic metachromatic dye, I:9-dimethyl methylene blue.

Authors:  K B Taylor; G M Jeffree
Journal:  Histochem J       Date:  1969-02

6.  Pitfalls of screening for mucopolysaccharidoses by the dimethylmethylene blue test.

Authors:  M Piraud; I Maire; M Mathieu
Journal:  Clin Chem       Date:  1993-01       Impact factor: 8.327

7.  Stability of urinary glycosaminoglycans in patients with mucopolysaccharidoses.

Authors:  Fernando Andrade; José Angel Prieto; Javier Elorz; Sergio Martín; Pablo Sanjurjo; Luis Aldámiz-Echevarría
Journal:  Clin Chim Acta       Date:  2007-10-11       Impact factor: 3.786

8.  MPS screening methods, the Berry spot and acid turbidity tests, cause a high incidence of false-negative results in sanfilippo and morquio syndromes.

Authors:  Chang Chih-Kuang; Lin Shuan-Pei; Lee Shyue-Jye; Wang Tuen-Jen
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

9.  Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase).

Authors:  J Edmond Wraith; Michael Beck; Roderick Lane; Ans van der Ploeg; Elsa Shapiro; Yong Xue; Emil D Kakkis; Nathalie Guffon
Journal:  Pediatrics       Date:  2007-06-04       Impact factor: 7.124

10.  [Clinical study of enzyme replacement therapy with idursulfase].

Authors:  L G Gutiérrez-Solana
Journal:  Rev Neurol       Date:  2007-02-19       Impact factor: 0.870

View more
  2 in total

1.  Detection by Urinary GAG Testing of Mucopolysaccharidosis Type II in an At-Risk Spanish Population.

Authors:  Laura López-Marín; Luis G Gutiérrez-Solana; Luis Aldamiz-Echevarria Azuara; Rogelio Simón de Las Heras; Anna Duat Rodríguez; Verónica Cantarín Extremera
Journal:  JIMD Rep       Date:  2013-02-02

Review 2.  Glycan-based biomarkers for mucopolysaccharidoses.

Authors:  Roger Lawrence; Jillian R Brown; Fred Lorey; Patricia I Dickson; Brett E Crawford; Jeffrey D Esko
Journal:  Mol Genet Metab       Date:  2013-07-29       Impact factor: 4.797

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.